Pneumonia Vaccine Market 2024-2033, Share, Size, Analysis, Growth, Report, Forecast:Type, Application, Trends, Developments
.png)
At a compound annual growth rate (CAGR) of 6.7%, The Pneumonia Vaccine Market was estimated to be worth USD 10.23 billion in 2022. Vaccines against pneumococcal disease, which is brought on by the bacteria Streptococcus pneumoniae, are intended to either prevent or lessen the illness's severity. Numerous symptoms, such as fever, coughing, chest pain, difficulty breathing, and exhaustion, can be brought on by pneumonia. Serious consequences, such sepsis and meningitis, can also result from pneumonia. Vaccinations against pneumococcal disease are advised for those who are more susceptible to the illness, such as infants and young children, adults who are older than 65, People with compromised immune systems, including those suffering from HIV/AIDS, cancer, or organ transplant recipients, People who suffer from long-term illnesses including diabetes, heart disease, or lung disease.
The market for pneumococcal vaccines is one that is
projected to continue rising quickly in the years to come. Numerous factors are
contributing to this trend, such as an aging population, an increase in
pneumococcal disease prevalence, growing vaccine awareness, and government
measures to boost immunization rates.
Request a
Glimpse of Our Sample Report: https://wemarketresearch.com/sample-request/pneumonia-vaccine-market/398
In terms of geography, the biggest markets for pneumococcal
vaccinations are in North America, Europe, and Asia-Pacific. Growth in these
regions is being driven by high vaccination rates, government backing for
immunization campaigns, and the high prevalence of pneumococcal illness in
North America and Europe. In the upcoming years, the Asia-Pacific market is
anticipated to expand quickly due to rising vaccination awareness and
government programs aimed at raising vaccination rates.
Pneumonia
Vaccine
Market:- Segmental Analysis
By Vaccine Type
·
Pneumococcal Polysaccharide Vaccines
·
Pneumococcal Conjugate Vaccines
By Product Type
·
Prevnar 13
·
Synflorix
·
Pneumovax23
By Distribution Channel
·
Pharmacies
·
Community Clinics
·
Public Health Agencies
Country Scope
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux;
Nordic Countries; Russia; China; India; Japan; South Korea; Australia;
Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South
Africa; Nigeria
Key Companies
Glaxosmithkline plc, LG Chem Ltd., Merck & Co., Inc.,
Panacea Biotec Limited, Pfizer Inc., Pnuvax Incorporated, Serum Institute of
India Pvt. Ltd., Shenzhen Kangtai Biological Products Co., Ltd., SK Bioscience,
and Walvax Biotechnology Co., Ltd.
Frequently Asked Questions
1.
What
is the market share (%) of Key Players?
2.
What
are the technology trends shaping various markets?
3.
What
is the market size and growth projection for each of the market segments and
sub-segments across Countries & Regions?
4.
What
is the Merger & Acquisition, New Product Launch, Recent Development within
each of the Markets?
6.
What
are the top performing segments, and countries / regions of each of the
markets?
7.
What
factors will influence demand and supply trends across each markets during the
forecast period?
8.
What
is the COVID-19 impact on the market and how long will it take to recover?
Purchase
this Report: https://wemarketresearch.com/purchase/pneumonia-vaccine-market/398?license=single
WE MARKET
RESEARCH is an established market analytics and research firm with a domain
experience sprawling across different industries. We have been working on
multi-county market studies right from our inception. Over the time, from our
existence, we have gained laurels for our deep rooted market studies and
insightful analysis of different markets.
Our
strategic market analysis and capability to comprehend deep cultural,
conceptual and social aspects of various tangled markets has helped us make a
mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in
helping numerous companies; both regional and international to successfully
achieve their business goals based on our in-depth market analysis. Moreover,
we are also capable of devising market strategies that ensure guaranteed
customer bases for our clients.
Contact
Us:
Mr. Robbin
Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: sales@wemarketresearch.com
Explore Our Blogs-
Comments
Post a Comment